Early intensification of combination antiretroviral therapy including FUZEON [enfuvirtide] in the treatment of progressive multifocal leucoencephalopathy during HIV-1 infection ANRS 125 trial.

Trial Profile

Early intensification of combination antiretroviral therapy including FUZEON [enfuvirtide] in the treatment of progressive multifocal leucoencephalopathy during HIV-1 infection ANRS 125 trial.

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Jan 2009

At a glance

  • Drugs Efavirenz; Emtricitabine; Enfuvirtide; Lopinavir/ritonavir; Tenofovir disoproxil fumarate
  • Indications HIV-1 infections; Progressive multifocal leukoencephalopathy
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 06 Feb 2008 Status changed from in progress to completed.
    • 01 Feb 2007 Status changed from recruiting to in progress
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top